Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,857 | 695 | 99.8% |
| Education | $32.86 | 5 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $1,663 | 71 | $0 (2024) |
| ABBVIE INC. | $1,453 | 108 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,009 | 45 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $924.01 | 54 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $900.26 | 50 | $0 (2024) |
| GlaxoSmithKline, LLC. | $884.68 | 31 | $0 (2024) |
| Merck Sharp & Dohme LLC | $800.28 | 44 | $0 (2024) |
| PFIZER INC. | $650.51 | 38 | $0 (2024) |
| Lilly USA, LLC | $648.59 | 31 | $0 (2024) |
| Gilead Sciences, Inc. | $441.14 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,994 | 89 | ABBVIE INC. ($373.55) |
| 2023 | $2,062 | 94 | GlaxoSmithKline, LLC. ($389.32) |
| 2022 | $2,089 | 95 | ABBVIE INC. ($403.02) |
| 2021 | $2,215 | 121 | Boehringer Ingelheim Pharmaceuticals, Inc. ($398.24) |
| 2020 | $992.88 | 57 | Janssen Pharmaceuticals, Inc ($230.46) |
| 2019 | $1,822 | 90 | Amgen Inc. ($318.48) |
| 2018 | $1,580 | 88 | Merck Sharp & Dohme Corporation ($283.01) |
| 2017 | $1,135 | 66 | Amgen Inc. ($175.52) |
All Payment Transactions
700 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: Endocrinology | ||||||
| 12/16/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.08 | General |
| Category: Bone Health | ||||||
| 12/16/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: HIV | ||||||
| 12/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.39 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.89 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $32.00 | General |
| Category: Bone Health | ||||||
| 10/17/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: Neuroscience | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: DIABETES | ||||||
| 10/03/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: Respiratory | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 09/26/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $22.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: RESPIRATORY | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $8.08 | General |
| Category: NEUROSCIENCE | ||||||
| 09/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Obesity | ||||||
| 09/12/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/10/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $22.20 | General |
| Category: Bone Health | ||||||
| 09/04/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Bone Health | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: PAIN | ||||||
| 08/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Oncology | ||||||
| 08/28/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,597 | 2,065 | $184,679 | $65,492 |
| 2022 | 35 | 1,565 | 2,053 | $189,283 | $65,151 |
| 2021 | 30 | 1,338 | 1,788 | $180,449 | $57,882 |
| 2020 | 27 | 1,212 | 1,623 | $171,627 | $48,234 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 104 | 220 | $54,556 | $20,116 | 36.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 91 | 91 | $23,751 | $12,019 | 50.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 75 | 107 | $19,572 | $6,265 | 32.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 35 | 45 | $15,030 | $5,780 | 38.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 115 | 138 | $7,176 | $2,271 | 31.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 159 | 262 | $7,860 | $2,201 | 28.0% |
| 77067 | Screening mammography | Office | 2023 | 19 | 19 | $3,876 | $1,890 | 48.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 11 | 11 | $4,301 | $1,850 | 43.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 132 | 166 | $8,632 | $1,718 | 19.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 96 | 116 | $5,104 | $1,714 | 33.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 104 | 109 | $3,052 | $1,430 | 46.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 140 | 174 | $7,830 | $1,324 | 16.9% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 19 | 20 | $3,640 | $1,296 | 35.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 49 | 49 | $1,078 | $927.08 | 86.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 42 | 53 | $3,498 | $504.56 | 14.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 25 | 28 | $1,484 | $504.56 | 34.0% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 19 | 19 | $969.00 | $491.91 | 50.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 12 | 14 | $1,134 | $440.70 | 38.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 16 | 16 | $1,216 | $362.24 | 29.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $470.00 | $346.17 | 73.7% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 20 | 25 | $575.00 | $334.00 | 58.1% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 27 | 40 | $760.00 | $331.60 | 43.6% |
| 81003 | Automated urinalysis test | Office | 2023 | 101 | 121 | $2,904 | $266.20 | 9.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 27 | 35 | $1,155 | $198.10 | 17.2% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 26 | 32 | $768.00 | $162.56 | 21.2% |
About Dr. George Demetrion, MD
Dr. George Demetrion, MD is a Internal Medicine healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2005. The National Provider Identifier (NPI) number assigned to this provider is 1326048950.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Demetrion, MD has received a total of $13,890 in payments from pharmaceutical and medical device companies, with $1,994 received in 2024. These payments were reported across 700 transactions from 58 companies. The most common payment nature is "Food and Beverage" ($13,857).
As a Medicare-enrolled provider, Demetrion has provided services to 5,712 Medicare beneficiaries, totaling 7,529 services with total Medicare billing of $236,759. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Portland, OR
- Active Since 07/26/2005
- Last Updated 10/16/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326048950
Products in Payments
- JARDIANCE (Drug) $801.28
- EVENITY (Biological) $689.81
- UBRELVY (Drug) $664.79
- VRAYLAR (Drug) $552.16
- INVOKANA (Drug) $493.03
- Prolia (Biological) $452.52
- ELIQUIS (Drug) $434.42
- QULIPTA (Drug) $421.15
- XARELTO (Drug) $310.77
- Aimovig (Biological) $302.31
- Otezla (Drug) $282.36
- TRADJENTA (Drug) $281.79
- DOVATO (Drug) $275.16
- FARXIGA (Drug) $263.20
- NURTEC ODT (Drug) $259.87
- SHINGRIX (Biological) $259.57
- VOQUEZNA (Drug) $250.00
- ENTRESTO (Drug) $241.73
- REXULTI (Drug) $224.08
- Kerendia (Drug) $191.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Portland
Nananda Col, Md, MD
Internal Medicine — Payments: $1.1M
Stephen Yau, M.d, M.D
Internal Medicine — Payments: $980,262
Ethan Korngold, Md, MD
Internal Medicine — Payments: $610,759
Dr. Firas Zahr, Md, MD
Internal Medicine — Payments: $543,624
Dr. Martin Moehlen, M.d, M.D
Internal Medicine — Payments: $318,908
Scott Chadderdon, Md, MD
Internal Medicine — Payments: $189,078